ADHD is primarily genetic, with inherited DNA accounting for roughly 74% of a person’s risk. But genes aren’t the whole picture. The remaining risk comes from a mix of environmental exposures, brain development differences, and the interplay between the two. About 11.3% of U.S. children ages 5 to 17 have been diagnosed with ADHD, making it one of the most common neurodevelopmental conditions in childhood.
Genetics Play the Largest Role
Across 37 twin studies, the average heritability of ADHD lands at 74%, meaning nearly three-quarters of the variation in who develops the condition traces back to genetics. If one identical twin has ADHD, the other is far more likely to have it than a fraternal twin would be. Family and adoption studies reinforce this: biological relatives of people with ADHD carry higher risk than adoptive relatives do.
There’s no single “ADHD gene.” Instead, the condition is polygenic, driven by many common gene variants that each nudge risk slightly. About a third of ADHD’s heritability comes from this polygenic component. Early research focused on genes involved in dopamine and norepinephrine signaling, since those are the chemical pathways targeted by ADHD medications. But results from those candidate gene studies were frequently contradictory, and the field has shifted toward large-scale genome scans that capture the condition’s true genetic complexity.
Interestingly, heritability estimates in adults are lower (30 to 40%) when based on self-reports alone. One study that combined self-reports with parent ratings pushed the adult estimate back up to 80%, suggesting that adults may underreport their own symptoms rather than that genes matter less as people age.
How the ADHD Brain Differs
Brain imaging studies consistently find structural differences in people with ADHD, particularly in regions responsible for planning, impulse control, and attention. Reduced gray matter volume has been documented in the prefrontal cortex (the brain’s executive control center), the anterior cingulate cortex (which helps detect errors and shift focus), and subcortical structures like the caudate nucleus and putamen that help regulate movement and reward processing. A 2025 study using advanced imaging correction methods found significant volume reductions in the right middle temporal region in children with ADHD compared to typically developing peers.
These aren’t dramatic, visible differences. They’re subtle volumetric variations that show up when researchers compare group averages across hundreds of brain scans. Some studies have even found larger volumes in certain areas, which highlights that ADHD brains aren’t simply “smaller” but are organized differently.
Dopamine, Norepinephrine, and Chemical Signaling
Two chemical messengers in the brain sit at the center of ADHD research: dopamine and norepinephrine. Dopamine helps regulate motivation, reward, and the ability to sustain attention on tasks that aren’t immediately interesting. Norepinephrine supports arousal, working memory, and the ability to stop yourself before acting impulsively. In ADHD, signaling through both of these systems appears to function differently.
This is why the medications that treat ADHD work. Stimulant medications increase the availability of both dopamine and norepinephrine in the brain, improving focus, impulse control, and working memory. Non-stimulant options work by blocking the transporter that reabsorbs norepinephrine, which also raises dopamine levels in brain regions that lack their own dedicated dopamine recycling system. The fact that targeting these two chemical pathways reliably improves ADHD symptoms is some of the strongest indirect evidence that they’re involved in the condition’s origin.
Serotonin, a third chemical messenger, has also been discussed in the context of ADHD, primarily because of its relationship with impulsivity and hyperactivity. But the evidence for dopamine and norepinephrine involvement is considerably stronger.
Environmental Risk Factors Before and After Birth
Genetics load the gun, but certain environmental exposures can pull the trigger. The most well-studied prenatal risk factor is maternal smoking during pregnancy. Children born to mothers who smoked do show higher rates of ADHD. However, studies that carefully account for shared genetics between mother and child (since mothers who smoke may themselves carry ADHD-related genes) suggest this link is probably not causal. The association likely reflects inherited genetic risk rather than a direct toxic effect of nicotine on the developing brain. Research on prenatal alcohol exposure and ADHD has been similarly inconsistent.
Premature birth, on the other hand, carries a clearer independent risk. A large national cohort study found that babies born extremely early (22 to 27 weeks) had an ADHD prevalence of 12.1%, compared to 4.5% for full-term babies, translating to roughly 2.4 times the risk. Even moderately preterm birth (28 to 33 weeks) raised prevalence to 7.0%. This association held regardless of whether the preterm birth was spontaneous or medically induced, and low birth weight did not explain the link. Something about early disruption to brain development during a critical window appears to increase vulnerability.
Lead Exposure and Toxins
Lead is one of the most consistent environmental risk factors for ADHD. A systematic review of 18 studies found a significant association between blood lead levels and at least one type of ADHD in 16 of them. Children with blood lead levels at or above 10 micrograms per deciliter had 2.4 times the risk of ADHD compared to children with lower levels. But the risk doesn’t start at some safe threshold. Children with levels between 5 and 10 had 66% higher odds of an ADHD diagnosis, and some research suggests even levels below 3 micrograms per deciliter may be associated with symptoms.
Prenatal exposure is particularly potent. One finding showed that doubling lead exposure during pregnancy was associated with a 3.4 times higher risk of hyperactivity in the child. The CDC currently recommends public health action for blood lead levels at or above 5 micrograms per deciliter, but no level has been identified as completely safe for children’s brain development.
Epigenetics: Where Genes and Environment Overlap
Environmental exposures don’t just act alongside genes. They can change how genes behave. This is the field of epigenetics, which studies chemical modifications to DNA that turn genes up or down without altering the genetic code itself. In ADHD research, toxic exposures, nutritional deficiencies, and stressful life events have all been linked to changes in these chemical tags on DNA.
One notable finding involves a specific site on the DRD4 gene, which codes for a type of dopamine receptor. Children with ADHD showed a distinct pattern of chemical modification at this site compared to children without the condition. This suggests that even among children who carry the same gene variant, differences in how actively that gene operates could influence whether ADHD develops. The research is still in early stages, but epigenetics helps explain why identical twins (who share 100% of their DNA) don’t always share an ADHD diagnosis.
The Evolutionary Angle
One persistent question is why ADHD-related genes remain so common if the condition causes real difficulties in modern life. Several evolutionary theories attempt to answer this. The most well-known is the hunter-farmer hypothesis, which proposes that traits associated with ADHD (high energy, quick reflexes, constantly scanning the environment, willingness to take risks) would have been advantageous for hunter-gatherers. Under this view, ADHD traits only became a disadvantage after the shift to agricultural societies that rewarded patience, routine, and sustained focus on repetitive tasks.
This falls under a broader concept called evolutionary mismatch: the idea that traits which helped survival in ancestral environments can become liabilities in modern ones. Genomic research has examined whether ADHD risk variants increased or decreased at specific points in human history, particularly around the Neolithic Revolution when farming began. The theory predicts that protective variants (those reducing ADHD risk) would have been positively selected during that cultural shift. While the hypothesis is intellectually appealing, the genomic evidence remains mixed, and ADHD is complex enough that no single evolutionary narrative fully explains its persistence.
What About Sugar?
The belief that sugar causes ADHD or worsens hyperactivity is one of the most widespread ideas about the condition. A meta-analysis of seven studies covering nearly 26,000 people did find a modest statistical association between sugar and sweetened beverage consumption and ADHD symptoms. But the studies had high variability in their methods and results, and the association doesn’t establish that sugar causes ADHD. Children with ADHD may simply gravitate toward sugary foods due to reward-seeking behavior, or shared lifestyle factors could explain both. Sugar is not considered a cause of ADHD in any clinical framework.
Who Gets Diagnosed
ADHD diagnosis rates vary across demographic groups in ways that reflect both biology and access to care. Boys are diagnosed at nearly twice the rate of girls (14.5% versus 8.0%), though growing evidence suggests girls are underdiagnosed because they more often present with inattentive symptoms rather than the hyperactive behavior that draws attention in classrooms. Diagnosis rates are higher among older children (14.3% for ages 12 to 17) than younger ones (8.6% for ages 5 to 11), likely because symptoms accumulate enough to prompt evaluation as academic demands increase.
Household income also plays a role. Children in families below the federal poverty line have an ADHD prevalence of 14.8%, compared to 10.1% in families at twice the poverty level or above. This gradient could reflect greater exposure to environmental risk factors like lead, higher levels of prenatal and childhood stress, or differences in how symptoms are managed and labeled across socioeconomic groups. Children with public insurance have the highest diagnosis rate (14.4%), while uninsured children have the lowest (6.3%), a gap that almost certainly reflects access to evaluation rather than actual differences in who has ADHD.